Alli Labels In U.S. Add Seizure Advisory Similar To E.U. Change
This article was originally published in The Tan Sheet
Executive Summary
GSK also recently posted to the alli brand website statements on why language was added to the Drug Facts panel for the orlistat 60 mg product. FDA contacted Glaxo in November 2013 requesting a supplement NDA for the label change, FDA’s Division of Nonprescription Clinical Evaluation said.
You may also be interested in...
Adding 20% Tax Would Curb Abuse Of OTC Drugs For Trimming Pounds, Research Suggests
National Eating Disorders Association-funded study projects tax would reduce purchases 10.3% for households with female children and 5.2% for all families. “Abuse of widely available, over-the-counter drugs and supplements such as diet pills, laxatives and diuretics by adolescents for weight control is well documented, yet manufacturers and retailers can sell them to minors without restriction,” says study author Bryn Austin of Harvard Medical School.
Adding 20% Tax Would Curb Abuse Of OTC Drugs For Trimming Pounds, Research Suggests
National Eating Disorders Association-funded study projects tax would reduce purchases 10.3% for households with female children and 5.2% for all families. “Abuse of widely available, over-the-counter drugs and supplements such as diet pills, laxatives and diuretics by adolescents for weight control is well documented, yet manufacturers and retailers can sell them to minors without restriction,” says study author Bryn Austin of Harvard Medical School.
In Brief: Shasun Buys Nuprin, DSM And GSK Earnings, Ad Claims Referred To FTC
Shasun acquires ibuprofen products; DSM predicts nutrition sales will increase; GSK sales fall on supply chain trouble; Nature’s Medicine Associates’ ad referred to FTC; Heinrich co-sponsors designer steroid bill; and AHPA eases botanical identification burden.